15. Overview of recent advancements in asthma management

Overview of recent advancements in asthma management

Download here 

CEUs: 2 Clinical

Average read time: 50 minutes.

Short Summary of the Article:

The article focuses on recent advancements in asthma management, particularly the move toward personalized medicine through the use of biologic agents. Asthma is presented as a complex, heterogeneous disease with various phenotypes and endotypes. The management of asthma involves addressing modifiable risk factors, optimizing inhaled pharmacotherapy, and considering biologic treatments for severe cases. The article emphasizes patient education, engagement, and the need for personalized management strategies based on specific asthma subtypes.

Learning Outcomes 

Upon completion of this activity, you should have an understanding of:

1. The Role of Personalized Medicine in Asthma Management: Learners will understand how biologic treatments are targeted toward specific asthma phenotypes and endotypes, improving patient outcomes.
2. Phenotypic and Endotypic Classification in Asthma: Learners will be able to identify different asthma phenotypes (e.g., allergic, eosinophilic) and endotypes (e.g., T2-high, T2-low), which guide the selection of appropriate therapies.
3. The Importance of Biologic Agents in Severe Asthma: Learners will explore the impact of biologic agents on reducing exacerbation rates and improving the quality of life in patients with severe asthma.

(Max of 3 Attempts)